Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Teresa Aydillo
Affiliation
Icahn School of Medicine at Mount Sinai
ORCID
Career Start Year
2011
Papers
37
H Index
23
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38054302
Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines.
Emerg Microbes Infect
2024
37313413
Group 1 and group 2 hemagglutinin stalk antibody response according to age.
Front Immunol
2023
35062328
Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses.
Viruses
2022
35776647
Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples.
STAR Protoc
2022
36496417
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.
NPJ Vaccines
2022
36112363
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
J Exp Med
2022
36219456
Immunodominance hierarchy after seasonal influenza vaccination.
Emerg Microbes Infect
2022
35247306
Limited extent and consequences of pancreatic SARS-CoV-2 infection.
Cell Rep
2022
35150638
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.
Cell Host Microbe
2022
33288923
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.
Nat Med
2021
33676971
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.
Gastroenterology
2021
33836156
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Cell
2021
33961839
Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
Hum Pathol
2021
34145263
Immunological imprinting of the antibody response in COVID-19 patients.
Nat Commun
2021
32511441
A serological assay to detect SARS-CoV-2 seroconversion in humans.
medRxiv
2020
33299999
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.
bioRxiv
2020
33182279
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.
Vaccines (Basel)
2020
33097660
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
Proc Natl Acad Sci U S A
2020
33294855
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients.
Cell Rep Med
2020
33123119
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients.
Front Immunol
2020
33259154
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
N Engl J Med
2020
32398876
A serological assay to detect SARS-CoV-2 seroconversion in humans.
Nat Med
2020
30787439
MHC class II proteins mediate cross-species entry of bat influenza viruses.
Nature
2019
31921042
Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins <i>in vitro</i> and <i>in vivo</i>.
Front Microbiol
2019
29321309
Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.
J Virol
2018
29635437
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.
Clin Infect Dis
2018
28362949
Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.
Clin Infect Dis
2017
27791106
Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.
Proc Natl Acad Sci U S A
2016
26232537
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.
Clin Microbiol Infect
2015
26246567
Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.
J Virol
2015
25168918
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.
Trials
2014
23692602
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.
Pediatr Transplant
2013
21792558
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.
Eur J Clin Microbiol Infect Dis
2012
23078072
Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease.
Clin Microbiol Infect
2012
22820034
Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave.
J Infect
2012
22377789
Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients.
Transplantation
2012
21831151
Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients.
Am J Transplant
2011
1 - 37 of 37
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
7
Carolina Lucas
Yale School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
1
Meagan E Deming
University of Maryland School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2009
Number of shared co-authors
3
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
6
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
0
Yasuko Hatta
FluGen Inc.
Career Start Year
2007
Number of shared co-authors
0
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Career Start Year
2007
Number of shared co-authors
1
Amber M Smith
University of California san francisco
Career Start Year
2006
Number of shared co-authors
7
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
5
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
12
Helen K B Talbot
Vanderbilt University Medical Center
Career Start Year
2005
Number of shared co-authors
1
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year
2003
Number of shared co-authors
4
Balaji Manicassamy
University of Iowa
Career Start Year
2002
Number of shared co-authors
23
Man-Seong Park
Korea University College of Medicine
Career Start Year
2001
Number of shared co-authors
9
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
7
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year
2000
Number of shared co-authors
0
Adam S Lauring
University of Michigan ann arbor
Career Start Year
1995
Number of shared co-authors
4
James D Chappell
Vanderbilt University Medical Center
Career Start Year
1995
Number of shared co-authors
0
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year
1993
Number of shared co-authors
31
Timothy M Uyeki
US Centers for Disease Control and Prevention
Career Start Year
1993
Number of shared co-authors
0
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
1993
Number of shared co-authors
16
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year
1991
Number of shared co-authors
7
Terrence M Tumpey
Centers for Disease Control and Prevention.
Career Start Year
1989
Number of shared co-authors
17
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
2
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
7
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year
1979
Number of shared co-authors
11
James E Crowe
Vanderbilt University Medical Center
Career Start Year
1975
Number of shared co-authors
4
Arnold S Monto
University of Michigan School of Public Health ann arbor
Career Start Year
1959
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
25
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers
5
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers
5
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers
5
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers
5
Jes??s Fort??n
Hospital Universitario Ramon y Cajal
Co-authored papers
5
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers
4
Ana S Gonzalez-Reiche
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Sumit K Chanda
The Scripps Research Institute
Co-authored papers
3
Juan Ayllon
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
David A Meekins
College of Veterinary Medicine, Kansas State University
Co-authored papers
3
Sadaf Aslam
University of South Florida
Co-authored papers
3
Christopher Benner
Michigan State University College of Human Medicine
Co-authored papers
3
Angel Bulnes-Ramos
Albert Einstein College of Medicine
Co-authored papers
3
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers
3
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Co-authored papers
3
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Ivan Marazzi
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers
2
Matthew T Weirauch
University of Cincinnati College of Medicine
Co-authored papers
2
Erna Milunka Kojic
Co-authored papers
2
Nan Zhao
Department of Computer Science and Informatics Institute, University of Missouri
Co-authored papers
2
Simin Zheng
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Phillip Cohen
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Laura Campisi
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Sven Heinz
U.C. San Diego School of Medicine
Co-authored papers
2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
2
1 - 30